Mwanasha Hamuza Merrill MD
Hematology/Oncology
Beth Israel deaconess internal medicine
Join to View Full Profile
330 Brookline AveBoston, MA 02215
Phone+1 617-667-7000
Dr. Merrill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2018 - 2021
Tufts University School of MedicineClass of 2018
Certifications & Licensure
CA State Medical License 2024 - 2026
MA State Medical License 2018 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A phase-2 study of pembrolizumab in patients with biologically selected subtypes of relapsed/refractory aggressive lymphomas.Mwanasha H Merrill, Robert A Redd, David C Fisher, Jeremy S Abramson, Jeffrey Barnes
Leukemia & Lymphoma. 2025-07-01 - Real-world Evidence of Duvelisib and Romidepsin in Relapsed/Refractory Peripheral and Cutaneous T-cell Lymphomas.Josie Ford, Min Jung Koh, Alexandra W Lenart, Caroline T MacVicar, Kusha Chopra
Blood Advances. 2025-06-17 - Forecasting optimal treatments in relapsed/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study.Mark N Sorial, Jessy Xinyi Han, Min Jung Koh, Leora Boussi, Sijia Li
British Journal of Haematology. 2025-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
